Learning Objectives: 

Review what we know about comorbidities in MS

Examine the prevalence of comorbidities in MS clinical trials

Evaluate the association of comorbidities with MS disease activity in clinical trials

Session date: 
03/20/2024 - 8:00am to 9:00am CDT
Location: 
D1.602
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.
Faculty List: 
Course Director(s)

Peter Sguigna, MD

has a financial relationship (Professional Services) with Clene NanoMedicine;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Bristol Myers Squibb;.
has a financial relationship (Intellectual Property Other) with VIC Tech;.
has a financial relationship (Independent contractor) with Medscape;.
has a financial relationship (Independent contractor) with Spherix Global Insights;.
has a financial relationship (Independent contractor) with Guidepoint;.
has a financial relationship (Independent contractor) with Horizon Therapeutics;.
has a financial relationship (Independent contractor) with EMD Serono;.
Peer reviewer(s)

Kan Ding, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Keysha Hale, N/A

has no relevant financial relationships to disclose at this time.

Zachary Roesch

has no relevant financial relationships to disclose at this time.
Speaker(s)

Amber Salter, PhD

has a financial relationship (Professional Services) with Gryphon Bio, LLC;.
has a financial relationship (Professional Services) with Abata Therapeutics;.